ProDx Health has announced a new partnership with Collective Corruption, making it the studio's official testing partner. This collaboration follows previous agreements with SextPanther and Bull Pen Content House, expanding ProDx Health's presence within the adult industry.

The partnership, announced on September 11, 2026, will provide studio talent at Collective Corruption with discounted access to ProDx Health’s Pro13 testing kits via a dedicated landing page. Dr. K, founder and CEO of ProDx Health, noted that Mickey, who owns Collective Corruption, has been a long-time tester with the company. Dr. K also stated that ProDx Health offers a special program for all studios that sign with them and anticipates announcing more studio partnerships in the near future.

Expanding Industry Presence

ProDx Health's agreement with Collective Corruption marks its third publicly announced partnership within the adult entertainment sector in 2026. On March 25, 2026, ProDx Health joined SextPanther as its new testing partner. Under this arrangement, models on the SextPanther platform receive a 25% discount code for ProDx Health’s Pro13 testing kits, accessible through a special landing page. ProDx Health was also slated for additional spotlighting in SextPanther resources and events.

Cathy, SextPanther Model Experience Manager, stated that SextPanther seeks to support its models' health and wellness and provide tools for industry success. Dr. K of ProDx Health expressed alignment with SextPanther, noting that models "rave about SextPanther" and that the company "cares about their models" and "goes the extra mile for them." Dr. K also mentioned that Kyle and Cathy have been "incredible to partner with."

Prior to the SextPanther announcement, on June 18, 2026, The Bull Pen Content House named ProDx Health as the official testing partner for its 2026 Bull Pen production. This event, scheduled for August 21–24 in Edmonton, Alberta, brings together creators for collaboration, networking, and content production. BullBossJosh, representing The Bull Pen, stated that ProDx Health joining as the official testing partner is a significant step in the safety standards for the production. He added that the Pro13 testing kits offer Mgen testing for Canadian participants, helping to protect U.S. participants and ensuring all creators use PASS-certified testing. BullBossJosh emphasized that the health and safety of everyone involved is a top priority.

The Bull Pen event's primary sponsor is Pearl Industry Network (PiN), which supports creators through free memberships, trusted industry partnerships, and access to resources. Other sponsors include Blew Ring, Popstar Supplements, and TrustyFans.

FDA Scrutiny

Amidst these partnerships, ProDx Health received a Warning Letter from the United States Food and Drug Administration (FDA) on February 10, 2026. The letter, referenced as CBER 26-720762, was addressed to Andreas Kogelnik, MD, PhD, Founder & Chief Executive Officer of ProDx Health, located at 1190 O'Brien Dr, Menlo Park, CA 94025, United States. The FDA delivered the letter via UPS and email to [email protected].

The FDA stated that ProDx Health was offering for sale human immunodeficiency virus (HIV) serological diagnostic sample self-collection kits without marketing authorization, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA determined that these sample self-collection kits are devices under section 201(h)(1) of the FD&C Act, 21 U.S.C. 321(h)(1), as they are intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body.

The FDA's review included ProDx Health’s website, last visited in February 2026, and the firm’s February 3, 2026, response to previous FDA correspondence. Based on this review, the FDA found that ProDx Health offers its sample self-collection kits for delivery to individuals, intending for these individuals to self-collect serological samples and ship them to laboratories for HIV testing. The FDA concluded that ProDx Health’s sample self-collection kits are adulterated.

Key Facts

  • ProDx Health partnered with Collective Corruption on September 11, 2026, to provide discounted Pro13 testing kits to studio talent.
  • ProDx Health previously partnered with SextPanther on March 25, 2026, offering a 25% discount on Pro13 testing kits to models.
  • On June 18, 2026, ProDx Health was named the official testing partner for The Bull Pen Content House's 2026 production, providing Mgen testing for Canadian participants and ensuring PASS-certified testing.
  • The FDA issued a Warning Letter to ProDx Health on February 10, 2026, for offering HIV serological diagnostic sample self-collection kits without marketing authorization.
  • Andreas Kogelnik, MD, PhD, is the Founder & Chief Executive Officer of ProDx Health.